Profile data is unavailable for this security.
About the company
Sprint Bioscience AB is a Sweden-based drug development company. It is engaged in the development of oncology therapeutics, focusing on cancer metabolism and liquid signaling. The Company's research is based on its fragment based drug discovery (FBDD) platform, which enables rapid indentifying of molecules with properties suitable for drug development. Its pipeline is divided in two research areas: cancer metabolism and autophagy, comprising products in the phases of establishing FBDD project and in the in vivo development. The Company’s strategy involves out-licensing or collaborating at an early stage of drug discovery in order to focus on current market needs.
- Revenue in SEK (TTM)85.01m
- Net income in SEK14.72m
- Incorporated2009
- Employees36.00
- LocationSprint Bioscience ABNovum, Halsovagen 7, Floor 8, elevator AHUDDINGE 141 57SwedenSWE
- Phone+46 84114455
- Websitehttps://www.sprintbioscience.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orphazyme A/S | 0.00 | -17.38m | 47.69m | 1.00 | -- | 1.95 | -- | -- | -325.75 | -325.75 | 0.00 | 455.65 | 0.00 | -- | -- | 0.00 | -42.26 | -76.08 | -50.77 | -105.34 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 32.00 | -- | -- | -- |
| Combigene AB | 1.91m | -36.52m | 49.90m | 10.00 | -- | 0.5269 | -- | 26.07 | -1.84 | -1.84 | 0.0967 | 4.78 | 0.0161 | -- | 3.71 | 239,265.00 | -30.66 | -13.00 | -32.33 | -14.58 | -- | -- | -1,908.16 | -58.77 | -- | -- | 0.00 | -- | -79.23 | 268.58 | -479.27 | -- | -24.02 | -- |
| Nidhogg Resources Holding AB (publ) | 32.00k | -4.21m | 54.09m | 3.00 | -- | 59.38 | -- | 1,690.42 | -0.0021 | -0.0021 | 0.00005 | 0.0005 | 0.0087 | -- | 0.0128 | 10,666.67 | -114.92 | -70.56 | -204.32 | -82.81 | -25,093.75 | -- | -13,156.25 | -- | -- | -- | -- | -- | -- | -- | 77.06 | -- | -- | -- |
| ViroGates A/S | 8.08m | -20.00m | 56.94m | 10.00 | -- | 4.01 | -- | 7.05 | -5.78 | -5.78 | 1.18 | 1.45 | 0.3331 | 0.3869 | 6.80 | 530,700.00 | -82.42 | -46.58 | -89.49 | -52.09 | 69.49 | 77.91 | -247.47 | -238.01 | 8.60 | -19.26 | 0.3626 | -- | -45.01 | 10.98 | -25.40 | -- | -- | -- |
| Modus Therapeutics Holding AB | 0.00 | -15.01m | 59.84m | 2.00 | -- | 6.08 | -- | -- | -0.5898 | -0.5898 | 0.00 | 0.2738 | 0.00 | -- | -- | 0.00 | -165.57 | -141.06 | -- | -278.44 | -- | -- | -- | -- | -- | -18.39 | 0.00 | -- | -- | -- | 2.31 | -- | -- | -- |
| Ultimovacs ASA | 0.00 | -174.02m | 61.19m | 23.00 | -- | 0.2899 | -- | -- | -5.21 | -5.21 | 0.00 | 6.32 | 0.00 | -- | -- | 0.00 | -51.97 | -28.80 | -57.15 | -31.12 | -- | -- | -- | -- | -- | -114.19 | 0.0137 | -- | -- | -- | -12.78 | -- | -45.35 | -- |
| Abera Bioscience AB | 0.00 | -7.63m | 62.48m | 6.00 | -- | 7.10 | -- | -- | -0.5213 | -0.5213 | 0.00 | 0.5733 | 0.00 | -- | -- | 0.00 | -73.37 | -79.42 | -98.59 | -96.10 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 13.74 | -- | -- | -- |
| PCI Biotech Holding ASA | 5.82m | -15.53m | 64.79m | 7.00 | -- | 2.09 | -- | 11.13 | -0.4287 | -0.4287 | 0.1607 | 0.8548 | 0.1334 | -- | 0.9365 | 857,000.00 | -35.59 | -36.44 | -40.42 | -40.14 | -- | -- | -266.74 | -1,055.43 | -- | -- | 0.0147 | -- | -37.05 | -20.78 | 63.13 | -- | -- | -- |
| Chosa Oncology AB | 5.00k | -8.58m | 76.62m | -- | -- | 3.54 | -- | 15,323.94 | -0.1745 | -0.1745 | 0.00009 | 0.3054 | 0.0002 | -- | 0.0009 | -- | -28.72 | -51.96 | -31.51 | -61.92 | -- | -- | -171,540.00 | -708.47 | -- | -28.22 | 0.00 | -- | -98.21 | -- | 28.33 | -- | -- | -- |
| Spago Nanomedical AB (publ) | 1.81m | -35.86m | 80.78m | 12.00 | -- | 1.62 | -- | 44.61 | -0.2614 | -0.2614 | 0.0106 | 0.1436 | 0.0386 | -- | 2.43 | 139,307.70 | -76.46 | -20.19 | -86.74 | -20.97 | -97.96 | -- | -1,980.40 | -4,853.45 | -- | -- | 0.00 | -- | 14.14 | -- | -7.72 | -- | -- | -- |
| Sprint Bioscience AB | 85.01m | 14.72m | 81.69m | 36.00 | 5.55 | 4.37 | 5.28 | 0.9609 | 0.2108 | 0.2108 | 1.22 | 0.2677 | 2.38 | -- | 13.18 | 3,036,214.00 | 41.28 | -71.22 | 128.58 | -113.71 | 76.51 | 62.75 | 17.31 | -110.22 | -- | -- | 0.00 | -- | 60,725.30 | 22.99 | 99.27 | -- | -26.02 | -- |
| Dextech Medical AB | 0.00 | -4.71m | 86.88m | 1.00 | -- | 2.93 | -- | -- | -0.2546 | -0.2546 | 0.00 | 1.60 | 0.00 | -- | -- | -- | -14.35 | -23.30 | -14.73 | -23.93 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -2.52 | -- | -- | -- |
| Coegin Pharma AB | 0.00 | -26.00m | 90.32m | 1.00 | -- | 4.19 | -- | -- | -2.25 | -2.25 | 0.00 | 1.06 | 0.00 | -- | -- | -- | -111.12 | -122.02 | -119.99 | -154.70 | -- | -- | -- | -28,466.75 | -- | -55.53 | 0.00 | -- | -- | -- | 20.60 | -- | -- | -- |
| Klaria Pharma Holding AB (publ) | -6.53m | -18.21m | 94.98m | 5.00 | -- | 4.57 | -- | -- | -0.1594 | -0.4121 | -0.0605 | 0.1603 | -0.0864 | -- | -- | -1,305,600.00 | -24.10 | -37.28 | -44.74 | -51.56 | -- | -- | -- | -2,077.34 | -- | -0.439 | 0.00 | -- | -100.00 | -- | 71.17 | -- | -- | -- |
| Prolight Diagnostics AB (publ) | 0.00 | -140.00m | 118.86m | 16.00 | -- | 0.8134 | -- | -- | -0.3853 | -0.3853 | 0.00 | 0.2447 | 0.00 | -- | -- | 0.00 | -66.82 | -- | -89.89 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -13.84 | -- |
Data as of Sep 20 2024. Currency figures normalised to Sprint Bioscience AB's reporting currency: Swedish Krona SEK
0.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FCG Fonder ABas of 30 Aug 2024 | 7.74k | 0.01% |
Data from 30 Aug 2024 - 30 Aug 2024Source: FactSet Research Systems Inc.
